Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis.

PubWeight™: 1.81‹?› | Rank: Top 3%

🔗 View Article (PMID 10629543)

Published in J Pathol on December 01, 1999

Authors

J V Bovée1, A M Cleton-Jansen, C Rosenberg, A H Taminiau, C J Cornelisse, P C Hogendoorn

Author Affiliations

1: Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands. JBovee@Pat.azl.nl

Articles citing this

PTHR1 mutations associated with Ollier disease result in receptor loss of function. Hum Mol Genet (2008) 1.20

Pathology of primary malignant bone and cartilage tumours. Int Orthop (2006) 1.07

Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma. Am J Pathol (2000) 1.05

Dedifferentiated chondrosarcoma--a fatal disease. J Cancer Res Clin Oncol (2005) 1.04

Chondrosarcoma: with updates on molecular genetics. Sarcoma (2011) 1.01

Spinal chondrosarcoma: a review. Sarcoma (2011) 1.00

Intermediate grade osteosarcoma and chondrosarcoma arising in an osteochondroma. A case report of a patient with hereditary multiple exostoses. J Clin Pathol (2002) 1.00

Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development. Am J Pathol (2001) 0.98

Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation. Virchows Arch (2007) 0.89

Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype. Mod Pathol (2016) 0.84

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone. BMC Cancer (2012) 0.82

Dedifferentiated peripheral chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of four cases. Virchows Arch (2012) 0.82

The molecular pathogenesis of dedifferentiated chondrosarcoma. Indian J Orthop (2014) 0.80

Common somatic alterations identified in maffucci syndrome by molecular karyotyping. Mol Syndromol (2014) 0.78

Is dedifferentiated chondrosarcoma a 'de-differentiated' chondrosarcoma? J Pathol (1999) 0.77

TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma. Tumour Biol (2016) 0.76

Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index, an implication for pathogenesis. Oncotarget (2016) 0.75

Dedifferentiated chondrosarcoma with leukocytosis and elevation of serum G-CSF. A case report. World J Surg Oncol (2006) 0.75

Dedifferentiated Chondrosarcoma of Proximal Tibia and Fibula with an Infected Ulcer: A Case Report. J Orthop Case Reports (2016) 0.75

Molecular pathology of chondroid neoplasms: part 2, malignant lesions. Skeletal Radiol (2006) 0.75

[Angiogenesis in cartilage tumors]. Pathologe (2010) 0.75

Articles by these authors

An STS-based map of the human genome. Science (1995) 17.72

Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science (2000) 8.64

Genes controlling early and late functions in symbiosis are located on a megaplasmid in Rhizobium meliloti. Mol Gen Genet (1981) 6.81

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06

Micrometastases and survival in stage II colorectal cancer. N Engl J Med (1998) 5.11

Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol (2001) 4.90

E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J (1995) 4.55

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet (1997) 3.68

Four genes of Medicago truncatula controlling components of a nod factor transduction pathway. Plant Cell (2000) 3.58

Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet (1996) 3.58

A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem (1993) 3.41

E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene (1996) 3.35

Megaplasmids in the plant-associated bacteria Rhizobium meliloti and Pseudomonas solanacearum. J Bacteriol (1982) 3.33

KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res (1988) 3.31

Agrobacterium rhizogenes-transformed roots of Medicago truncatula for the study of nitrogen-fixing and endomycorrhizal symbiotic associations. Mol Plant Microbe Interact (2001) 3.25

Signaling and host range variation in nodulation. Annu Rev Microbiol (1992) 3.17

Transfer of Rhizobium meliloti pSym genes into Agrobacterium tumefaciens: host-specific nodulation by atypical infection. J Bacteriol (1984) 3.03

Intron phase correlations and the evolution of the intron/exon structure of genes. Proc Natl Acad Sci U S A (1995) 2.98

E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer (2006) 2.74

Identification of a Rhizobium meliloti pSym2011 region controlling the host specificity of root hair curling and nodulation. J Bacteriol (1985) 2.69

Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet (2005) 2.60

Rapid subchromosomal localization of cosmids by nonradioactive in situ hybridization. Cytogenet Cell Genet (1990) 2.60

TRPC1, a human homolog of a Drosophila store-operated channel. Proc Natl Acad Sci U S A (1995) 2.56

Myxoid tumours of soft tissue. Histopathology (1999) 2.53

Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet (1994) 2.45

Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet (1989) 2.44

Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization. Clin J Pain (1993) 2.40

Visual loss in pregnant women with pituitary adenomas. Ann Intern Med (1994) 2.27

Immunoglobulin containing cells in inflammatory bowel disease of the colon: a morphometric and immunohistochemical study. Gut (1980) 2.24

Assignment of symbiotic developmental phenotypes to common and specific nodulation (nod) genetic loci of Rhizobium meliloti. J Bacteriol (1986) 2.20

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol (1997) 2.15

Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet (2008) 2.09

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer (1997) 2.02

Ever since Knudson. Trends Genet (2001) 1.96

Two subsets of human alphoid repetitive DNA show distinct preferential localization in the pericentric regions of chromosomes 13, 18, and 21. Cytogenet Cell Genet (1986) 1.90

Relationship between "proto-splice sites" and intron phases: evidence from dicodon analysis. Proc Natl Acad Sci U S A (1998) 1.90

Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene (1991) 1.81

A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet (1992) 1.80

Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol (2000) 1.80

PCR artifacts in LOH and MSI analysis of microdissected tumor cells. Hum Pathol (2000) 1.77

EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet (1999) 1.70

Endogenous hormones and breast cancer: a prospective cohort study. Breast Cancer Res Treat (1991) 1.68

Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res (1988) 1.67

Sequence heterogeneity within the human alphoid repetitive DNA family. Nucleic Acids Res (1986) 1.65

DNA ploidy and survival in breast cancer patients. Cytometry (1987) 1.65

Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills. Mol Psychiatry (2006) 1.64

Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer (2000) 1.64

Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining. Am J Pathol (1991) 1.63

Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Lab Invest (2000) 1.62

Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma. AJR Am J Roentgenol (1997) 1.61

Genomic imbalances associated with mullerian aplasia. J Med Genet (2007) 1.61

The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol (2001) 1.60

Assessment of the validity and utility of a sleep-symptom questionnaire. Am J Respir Crit Care Med (1994) 1.58

Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas. Eur J Cancer (2004) 1.58

Rhizobium meliloti host range nodH gene determines production of an alfalfa-specific extracellular signal. J Bacteriol (1988) 1.57

Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer. Cytometry (1991) 1.57

At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics (1989) 1.55

Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue. J Pathol (1992) 1.55

Somatic genetic changes in human breast cancer. Biochim Biophys Acta (1994) 1.55

Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res (1989) 1.55

Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature. Cancer (1999) 1.54

Flow cytometric detection of aneuploidy in colorectal adenomas. Cancer Res (1985) 1.53

Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res (1992) 1.53

Nora's lesion, a distinct radiological entity? Skeletal Radiol (2006) 1.52

Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet (2001) 1.51

At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer (1994) 1.50

Neuropsychological function in mild sleep-disordered breathing. Sleep (1997) 1.48

Plasmids in Frankia sp. J Bacteriol (1983) 1.45

Structural organization and regulation of the small proline-rich family of cornified envelope precursors suggest a role in adaptive barrier function. J Biol Chem (2001) 1.43

Fragile X frequency in a mentally retarded population in Brazil. Am J Med Genet (1990) 1.42

[From gene to disease; from BRCA1 or BRCA2 to breast cancer]. Ned Tijdschr Geneeskd (2000) 1.41

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant. J Med Genet (2004) 1.39

Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma. Genes Chromosomes Cancer (1999) 1.37

Subdivision of S-phase by analysis of nuclear 5-bromodeoxyuridine staining patterns. Cytometry (1989) 1.37

Whole-genome array-CGH screening in undiagnosed syndromic patients: old syndromes revisited and new alterations. Cytogenet Genome Res (2006) 1.34

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer (1995) 1.33

High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma. J Clin Pathol (2001) 1.33

Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer (2001) 1.32

Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia (1999) 1.32

Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior. J Bone Joint Surg Am (1994) 1.31

Diagnostic morphometry of isolated lymph node cells from patients with mycosis fungoides and Sézary's syndrome. Virchows Arch B Cell Pathol Incl Mol Pathol (1980) 1.29

Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology (2000) 1.28

Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med (1998) 1.27